Literature DB >> 20808563

Clinical trial information as a measure of quality cancer care.

Wei Chua1, Stephen J Clarke.   

Abstract

Participation in clinical trials enables patients to access new treatment options. Evidence shows improved outcomes in participants compared with nonparticipants in non-small-cell, lung, breast, colorectal, and testicular cancers.

Entities:  

Year:  2010        PMID： 20808563      PMCID： PMC2868649          DOI： 10.1200/JOP.091099

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN： 1554-7477            Impact factor:   3.840


  12 in total

1.  Developing a system to assess the quality of cancer care: ASCO's national initiative on cancer care quality.

Authors:  Eric C Schneider; Jennifer L Malin; Katherine L Kahn; Ezekiel J Emanuel; Arnold M Epstein
Journal:  J Clin Oncol       Date:  2004-08-01       Impact factor: 44.544

2.  The quality oncology practice initiative: assessing and improving care within the medical oncology practice.

Authors:  Kristen McNiff
Journal:  J Oncol Pract       Date:  2006-01       Impact factor: 3.840

3.  ASCO-ESMO consensus statement on quality cancer care.

Authors: 
Journal:  J Clin Oncol       Date:  2006-06-02       Impact factor: 44.544

4.  Clinical trial enrollment, patient characteristics, and survival differences in prospectively registered metastatic colorectal cancer patients.

Authors:  Halfdan Sorbye; Per Pfeiffer; Nina Cavalli-Björkman; Camilla Qvortrup; Mari H Holsen; Tore Wentzel-Larsen; Bengt Glimelius
Journal:  Cancer       Date:  2009-10-15       Impact factor: 6.860

Review 5.  Access to quality cancer care: consensus statement. American Federation of Clinical Oncologic Societies.

Authors: 
Journal:  J Clin Oncol       Date:  1998-04       Impact factor: 44.544

6.  A process for measuring the quality of cancer care: the Quality Oncology Practice Initiative.

Authors:  Michael N Neuss; Christopher E Desch; Kristen K McNiff; Peter D Eisenberg; Dean H Gesme; Joseph O Jacobson; Mohammad Jahanzeb; Jennifer J Padberg; John M Rainey; Jeff J Guo; Joseph V Simone
Journal:  J Clin Oncol       Date:  2005-08-08       Impact factor: 44.544

7.  Analysis of the prognostic effects of inclusion in a clinical trial and of myelosuppression on survival after adjuvant chemotherapy for breast carcinoma.

Authors:  C Mayers; T Panzarella; I F Tannock
Journal:  Cancer       Date:  2001-06-15       Impact factor: 6.860

Review 8.  Cancer care quality measures: diagnosis and treatment of colorectal cancer.

Authors:  Meenal B Patwardhan; Gregory P Samsa; Douglas C McCrory; Deborah A Fisher; Christopher R Mantyh; Michael A Morse; Robert G Prosnitz; Kathryn E Cline; Rebecca N Gray
Journal:  Evid Rep Technol Assess (Full Rep)       Date:  2006-05

9.  After a treatment breakthrough: a comparison of trial and population-based data for advanced testicular cancer.

Authors:  E J Feuer; C M Frey; O W Brawley; S G Nayfield; J B Cunningham; N L Geller; G J Bosl; B S Kramer
Journal:  J Clin Oncol       Date:  1994-02       Impact factor: 44.544

10.  American Society of Clinical Oncology Statement on minimum standards and exemplary attributes of clinical trial sites.

Authors:  Robin Zon; Neal J Meropol; Robert B Catalano; Richard L Schilsky
Journal:  J Clin Oncol       Date:  2008-04-07       Impact factor: 44.544
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.